• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    5.80 Down 0.11(1.86%) Feb 27, 4:00PM EST
    |After Hours : 5.80 Down 0.00 (0.01%) Feb 27, 4:38PM EST
    Add to Portfolio
    Prev Close:5.91
    Open:5.99
    Bid:5.37 x 200
    Ask:6.94 x 1000
    1y Target Est:11.13
    Beta:2.14
    Next Earnings Date: 2-Mar-15ECYT Earnings announcement
    Day's Range:5.71 - 5.99
    52wk Range:5.01 - 33.70
    Volume:457,478
    Avg Vol (3m):574,662
    Market Cap:241.92M
    P/E (ttm):21.64
    EPS (ttm):0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ECYTDown 1.86%241.92M
    NKTRUp 0.69%1.72B
    RHHBYUp 0.80%N/A
    SNSS 0.00%137.53M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.81
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.06
    Quarterly EPS Est (Dec-14) :-0.25
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback